THC
Tenet Healthcare Corporation NYSE Listed Mar 17, 1980$194.03
Mkt Cap $16.7B
52w Low $146.60
47.1% of range
52w High $247.21
50d MA $204.56
200d MA $197.22
P/E (TTM)
11.7x
EV/EBITDA
6.6x
P/B
1.9x
Debt/Equity
3.1x
ROE
4.6%
P/FCF
7.1x
RSI (14)
—
ATR (14)
—
Beta
1.50
50d MA
$204.56
200d MA
$197.22
Avg Volume
1.2M
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
14201 Dallas Parkway · Dallas, TX 75254 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 4.21 | 4.82 | +14.5% | 177.12 | +1.1% | +3.5% | +1.1% | +0.8% | +4.1% | -0.2% | — |
| Feb 11, 2026 | TNS | 4.07 | 4.70 | +15.5% | 226.35 | +0.0% | +2.6% | -0.5% | +1.4% | -1.1% | -1.6% | — |
| Oct 28, 2025 | TNS | 3.34 | 3.70 | +10.8% | 204.62 | +0.4% | +2.2% | -0.2% | -1.0% | -2.5% | +3.1% | — |
| Jul 22, 2025 | TNS | 2.87 | 4.02 | +40.1% | 155.97 | +1.2% | +1.5% | -6.3% | +3.1% | +2.3% | -0.3% | — |
| Apr 29, 2025 | TNS | 3.12 | 4.36 | +39.7% | 138.35 | -0.9% | +3.3% | +1.6% | +1.9% | +0.7% | +1.6% | — |
| Feb 12, 2025 | TNS | 2.95 | 3.44 | +16.6% | 126.19 | +1.4% | +5.8% | -0.2% | +1.2% | +0.5% | +1.2% | — |
| Oct 29, 2024 | TNS | 2.33 | 2.93 | +25.8% | 162.76 | -1.0% | -2.9% | -1.9% | +0.7% | +4.0% | +2.8% | — |
| Jul 24, 2024 | TNS | 1.90 | 2.31 | +21.6% | 145.34 | +0.6% | +3.0% | +1.3% | +0.8% | -1.8% | -0.3% | — |
| Apr 30, 2024 | TNS | 1.45 | 3.22 | +122.1% | 112.29 | +0.5% | +3.3% | +2.6% | +1.1% | +1.7% | +1.4% | — |
| Feb 8, 2024 | TNS | 1.60 | 2.68 | +67.5% | 89.02 | +0.3% | -1.0% | +2.8% | -2.7% | -0.1% | +2.2% | — |
| Oct 30, 2023 | TNS | 1.20 | 1.44 | +20.0% | 53.25 | -1.3% | +0.8% | -1.1% | +1.6% | +1.8% | -0.6% | — |
| Jul 31, 2023 | TNS | 1.25 | 1.44 | +15.2% | 74.73 | +2.5% | +2.7% | -3.5% | +0.3% | +0.2% | +1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $177.12 | $179.11 | +1.1% | +3.5% | +1.1% | +0.8% | +4.1% | -0.2% |
| May 1 | Guggenheim | Maintains | Buy → Buy | — | $177.12 | $179.11 | +1.1% | +3.5% | +1.1% | +0.8% | +4.1% | -0.2% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $177.12 | $179.11 | +1.1% | +3.5% | +1.1% | +0.8% | +4.1% | -0.2% |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $177.12 | $179.11 | +1.1% | +3.5% | +1.1% | +0.8% | +4.1% | -0.2% |
| Mar 12 | Mizuho | Maintains | Outperform → Outperform | — | $234.58 | $233.09 | -0.6% | -4.2% | +1.3% | -3.7% | -3.5% | -4.0% |
| Mar 12 | Guggenheim | Maintains | Buy → Buy | — | $234.58 | $233.09 | -0.6% | -4.2% | +1.3% | -3.7% | -3.5% | -4.0% |
| Feb 20 | Leerink Partners | Maintains | Outperform → Outperform | — | $228.08 | $227.66 | -0.2% | +0.8% | +1.7% | +1.6% | -0.2% | +1.1% |
| Feb 17 | Truist | Maintains | Buy → Buy | — | $231.10 | $233.04 | +0.8% | +1.4% | -1.1% | -1.6% | +0.8% | +1.7% |
| Feb 13 | Guggenheim | Maintains | Buy → Buy | — | $232.26 | $231.16 | -0.5% | -0.5% | +1.4% | -1.1% | -1.6% | +0.8% |
| Feb 13 | Barclays | Maintains | Overweight → Overweight | — | $232.26 | $231.16 | -0.5% | -0.5% | +1.4% | -1.1% | -1.6% | +0.8% |
| Feb 12 | RBC Capital | Maintains | Outperform → Outperform | — | $226.35 | $226.35 | +0.0% | +2.6% | -0.5% | +1.4% | -1.1% | -1.6% |
| Feb 12 | UBS | Maintains | Buy → Buy | — | $226.35 | $226.35 | +0.0% | +2.6% | -0.5% | +1.4% | -1.1% | -1.6% |
| Feb 12 | Jefferies | Maintains | Buy → Buy | — | $226.35 | $226.35 | +0.0% | +2.6% | -0.5% | +1.4% | -1.1% | -1.6% |
| Feb 12 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $226.35 | $226.35 | +0.0% | +2.6% | -0.5% | +1.4% | -1.1% | -1.6% |
| Feb 3 | RBC Capital | Maintains | Outperform → Outperform | — | $188.03 | $193.68 | +3.0% | +2.6% | -1.1% | +2.8% | +2.8% | -4.2% |
| Jan 7 | TD Cowen | Maintains | Buy → Buy | — | $208.24 | $207.05 | -0.6% | -3.0% | +0.7% | -1.1% | -0.8% | -0.2% |
| Jan 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $208.24 | $207.05 | -0.6% | -3.0% | +0.7% | -1.1% | -0.8% | -0.2% |
| Dec 2 | Guggenheim | Maintains | Buy → Buy | — | $215.13 | $222.00 | +3.2% | -0.1% | -1.6% | +0.4% | -1.0% | -1.8% |
| Nov 21 | Barclays | Maintains | Overweight → Overweight | — | $186.68 | $188.78 | +1.1% | +2.8% | +11.8% | +1.8% | -0.5% | -0.3% |
| Nov 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $199.99 | $199.02 | -0.5% | -1.7% | -1.9% | -0.3% | +0.3% | +0.6% |
| Nov 13 | JP Morgan | Maintains | Overweight → Overweight | — | $199.99 | $199.02 | -0.5% | -1.7% | -1.9% | -0.3% | +0.3% | +0.6% |
| Nov 3 | Truist | Maintains | Buy → Buy | — | $206.49 | $205.78 | -0.3% | -2.5% | +3.1% | +0.4% | -2.1% | +0.5% |
| Oct 30 | RBC Capital | Maintains | Outperform → Outperform | — | $209.14 | $208.04 | -0.5% | -0.2% | -1.0% | -2.5% | +3.1% | +0.4% |
| Oct 29 | Guggenheim | Maintains | Buy → Buy | — | $204.62 | $205.34 | +0.4% | +2.2% | -0.2% | -1.0% | -2.5% | +3.1% |
| Oct 29 | UBS | Maintains | Buy → Buy | — | $204.62 | $205.34 | +0.4% | +2.2% | -0.2% | -1.0% | -2.5% | +3.1% |
| Oct 29 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $204.62 | $205.34 | +0.4% | +2.2% | -0.2% | -1.0% | -2.5% | +3.1% |
| Oct 17 | Mizuho | Maintains | Outperform → Outperform | — | $199.13 | $199.13 | +0.0% | +0.4% | +1.1% | +0.1% | +1.4% | +0.9% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $204.83 | $204.69 | -0.1% | -2.1% | -2.8% | -2.7% | +0.2% | +3.3% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $199.76 | $201.12 | +0.7% | +2.5% | -2.1% | -2.8% | -2.7% | +0.2% |
| Oct 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $199.76 | $201.12 | +0.7% | +2.5% | -2.1% | -2.8% | -2.7% | +0.2% |
| Sep 18 | Barclays | Maintains | Overweight → Overweight | — | $183.47 | $185.00 | +0.8% | +3.7% | -0.1% | +2.1% | -0.5% | +1.8% |
| Sep 10 | BofA Securities | Maintains | Buy → Buy | — | $196.39 | $198.08 | +0.9% | -2.3% | +0.8% | -0.3% | -3.1% | -2.1% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $180.23 | $179.71 | -0.3% | -0.1% | +1.1% | +1.4% | -0.1% | +0.6% |
| Aug 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $171.87 | $171.14 | -0.4% | +0.3% | -0.2% | -0.4% | +3.9% | +2.2% |
| Aug 4 | JP Morgan | Maintains | Overweight → Overweight | — | $158.09 | $158.70 | +0.4% | +1.9% | -0.5% | -0.6% | +2.6% | +1.3% |
| Jul 28 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $153.02 | $151.63 | -0.9% | +2.3% | -0.3% | +3.1% | +0.2% | -2.0% |
| Jul 25 | Baird | Maintains | Neutral → Neutral | — | $148.38 | $149.00 | +0.4% | +3.1% | +2.3% | -0.3% | +3.1% | +0.2% |
| Jul 24 | Barclays | Maintains | Overweight → Overweight | — | $158.31 | $157.94 | -0.2% | -6.3% | +3.1% | +2.3% | -0.3% | +3.1% |
| Jul 23 | UBS | Maintains | Buy → Buy | — | $155.97 | $157.77 | +1.2% | +1.5% | -6.3% | +3.1% | +2.3% | -0.3% |
| Jul 23 | BofA Securities | Maintains | Buy → Buy | — | $155.97 | $157.77 | +1.2% | +1.5% | -6.3% | +3.1% | +2.3% | -0.3% |
| Jul 23 | Guggenheim | Maintains | Buy → Buy | — | $155.97 | $157.77 | +1.2% | +1.5% | -6.3% | +3.1% | +2.3% | -0.3% |
| Jul 23 | Raymond James | Maintains | Outperform → Outperform | — | $155.97 | $157.77 | +1.2% | +1.5% | -6.3% | +3.1% | +2.3% | -0.3% |
| Jul 16 | Truist | Maintains | Buy → Buy | — | $172.78 | $171.13 | -1.0% | +0.4% | +1.0% | -0.0% | -0.2% | -10.7% |
| Jul 11 | Mizuho | Maintains | Outperform → Outperform | — | $173.66 | $172.25 | -0.8% | +1.2% | +1.1% | -2.8% | +0.4% | +1.0% |
| Jun 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $171.46 | $171.07 | -0.2% | -3.1% | -5.8% | +3.1% | +2.6% | -0.7% |
| Jun 2 | Barclays | Maintains | Overweight → Overweight | — | $168.77 | $169.13 | +0.2% | +0.8% | +1.0% | -1.1% | +1.1% | -0.2% |
| May 29 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $164.67 | $167.54 | +1.7% | +1.0% | +1.5% | +0.8% | +1.0% | -1.1% |
| May 14 | BofA Securities | Maintains | Buy → Buy | — | $157.70 | $157.35 | -0.2% | +1.2% | +2.8% | +0.9% | +1.1% | +0.8% |
| May 12 | Truist | Maintains | Buy → Buy | — | $148.83 | $153.52 | +3.2% | +3.9% | +2.0% | +1.2% | +2.8% | +0.9% |
| May 5 | Goldman Sachs | Maintains | Neutral → Neutral | — | $148.03 | $147.80 | -0.2% | +0.7% | +1.6% | +0.6% | -2.1% | -0.2% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A senior executive departure at Terraces Health Care (THC) creates immediate leadership uncertainty and potential operational disruption, warranting investor caution until succession clarity emerges.
Apr 10
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive hire with substantial sign-on incentives signals management transition and potential strategic shift, which investors should monitor for operational direction changes and whether this leader can drive shareholder value.
Mar 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Without seeing the actual press release content, I cannot provide specific analysis; however, investors should review Exhibit 99.1 immediately to assess whether disclosed matters affect earnings guidance, operations, or competitive positioning.
Mar 12
8-K
Tenet Healthcare Corporation New -- 8-K Filing
Tenet Healthcare's 2025 net income fell 56% year-over-year to $1.407 billion despite management confidence in executing strategy and meeting full-year 2026 guidance.
Feb 11
8-K · 8.01
!! High
Tenet Healthcare Corporation New -- 8-K 8.01: Material Event / Announcement
Tenet Healthcare's agreement with Conifer Health and CommonSpirit Health reduces its balance sheet liabilities by approximately $885 million through a redeemable non-controlling interest reduction.
Feb 2
Data updated apr 27, 2026 4:40am
· Source: massive.com